BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter Fiscal Year 2012

ELMWOOD PARK, N.J.--()--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the second quarter of Fiscal 2012 before the open of market trading on Thursday, June 7, 2012. The Company’s earnings conference call is to take place the same day at 10:30 a.m. EDT. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.

The live Web cast will be available at the Company’s corporate Web site, www.bioreference.com and through www.streetevents.com. To listen to the live call please go to the Web site ten minutes before the conference call is scheduled to begin. You will need to register as well as download and install any necessary audio software. The Web cast will be archived, on both Web sites, for 30 days following the call.

About BioReference Laboratories, Inc.

BRLI is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. We believe that we are the fourth largest full-service laboratory in the United States and the largest independent regional laboratory in the Northeastern market. BRLI offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. BRLI primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, women’s health and correctional health care.

www.bioreference.com

Contacts

BioReference Laboratories, Inc.
Tara Mackay, 201-791-2600
Investor Relations Coordinator
Fax: 201-791-1941
tmackay@bioreference.com

Sharing

Contacts

BioReference Laboratories, Inc.
Tara Mackay, 201-791-2600
Investor Relations Coordinator
Fax: 201-791-1941
tmackay@bioreference.com